OVCAR-4 Cells
Información general
| Organismo | Homo sapiens (Human) |
|---|---|
| Tejido | Metastatic |
| Enfermedad | High grade ovarian serous adenocarcinoma |
| Sitio metastásico | Ascites |
| Sinónimos | OVCAR 4, NIH:OVCAR-4, NIH:OVCAR4, OVCAR.4, OVCAR4, Ovcar4 |
Características
| Edad | 42Y |
|---|---|
| Género | Female |
| Etnia | Caucasian |
Datos reglamentarios
| Cita | OVCAR-4 (Cytion catalog number 305912) |
|---|---|
| NCBI_TaxID | 9606 |
| CellosaurusAccesión | CVCL_1627 |
Datos biomoleculares
| Perfil mutacional | Mutation: p.Leu130Val, Homozygous |
|---|
Manejo de
| Tiempo de duplicación | 34 hours ; 43 hours ; 41.4 hours |
|---|---|
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad / Perfil genético / HLA
| Sitio metastásico: | Ascitis |
|---|
Certificado de análisis (CdA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305912-040326 | Certificado de análisis | 31. Mar. 2026 | 305912 |
Acuerdo de transferencia de material
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.